Catalog Products » Recombinant Proteins » HSV-1 gG, Herpes Simplex Virus Antigen, Recombinant
Search by Catalog Number :
Search by Name :
Search by Sequence : (One letter code)
Search by Category :

HSV-1 gG, Herpes Simplex Virus Antigen, Recombinant

*This product has been discontinued! *

Full Name HSV-1 gG, Herpes Simplex Virus Antigen, Recombinant
Abbreviated Name-1
Herpes Simplex Virus-1 gG;
Herpes Simplex Virus (HSV)-1 gG is an E. coli-derived recombinant. GenScript Herpes Simplex Virus (HSV)-1 gG contains the HSV-1 gG immunodominant regions.
E. coli
The protein is over 95% pure as determined by 10% PAGE (Coomassie staining).
Store the protein at -20°C. Keep container tightly closed.
1 mg/ml in 25 mM Tris-HCl, 1 mM EDTA, 50% glycerol
The protein will remain stable for one year if stored frozen and for one month if stored in solution at room temperature.
This protein is immunoreactive with the sera of HSV-infected individuals.
The protein makes a good antigen in ELISA and Western Blots, and an excellent antigen for the detection of HSV with minimal specificity problems.
Tran LC, Kissner JM et al. A herpes simplex virus 1 recombinant lacking the glycoprotein G coding sequences is defective in entry through apical surfaces of polarized epithelial cells in culture and in vivo. Proc Natl Acad Sci U S A. Feb 2000;97(4):1818-22.

Sullivan V, Smith GL. Expression and characterization of herpes simplex virus type 1 (HSV-1) glycoprotein G (gG) by recombinant vaccinia virus: neutralization of HSV-1 infectivity with anti-gG antibody. J Gen Virol. Oct 1987;68:2587-98.

Rekabdar E, Tunback P et al. Dichotomy of glycoprotein g gene in herpes simplex virus type 1 isolates. J Clin Microbiol. Sep 2002;40(9):3245-51.

Custom Recombinant Protein Services: Guaranteed E. coli Expression Package-3 mg purified soluble protein from $2,200 .
Bacterial Expression System: GenScript has developed BacPowerTM technologies to tackle hard-to-express and hard-to-dissolve proteins.
Yeast Expression System: GenScript's proprietary YeastHIGHTM technology combines the advantages of the bacterial and eukaryotic expression systems.
Baculovirus/Insect Cell Expression System: GenScript developed BacuVanceTM platform for the secretion of recombinant proteins from baculovirus-infected insect cells.
Mammalian Cell Expression System: The proprietary 293 and CHO suspension system platform promotes fast production and delivery of recombinant proteins and monoclonal antibodies up to grams level.